--- title: "12 Health Care Stocks Moving In Monday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/281060490.md" description: "In Monday's trading session, Bullfrog AI Holdings (BFRG) saw a significant gain of 175.4%, reaching $1.4, while Iterum Therapeutics (ITRM) rose by 103.65% to $0.07. Other notable gainers included SeaStar Medical (ICU) up 30.29%, and Apollomics (APLM) up 23.98%. Conversely, Scienture Holdings (SCNX) experienced a sharp decline of 37.6% to $0.26, with Viridian Therapeutics (VRDN) down 33.36% to $18.25. Overall, several health care stocks showed considerable volatility in their prices during the session." datetime: "2026-03-30T17:05:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281060490.md) - [en](https://longbridge.com/en/news/281060490.md) - [zh-HK](https://longbridge.com/zh-HK/news/281060490.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Monday's Intraday Session ### Gainers - **Bullfrog AI Hldgs** (NASDAQ:BFRG) stock rose 175.4% to $1.4 during Monday's regular session. The market value of their outstanding shares is at $6.4 million. - **Iterum Therapeutics** (NASDAQ:ITRM) stock increased by 103.65% to $0.07. The company's market cap stands at $1.8 million. - **SeaStar Medical Holding** (NASDAQ:ICU) stock rose 30.29% to $3.57. The company's market cap stands at $10.4 million. The company's, Q4 earnings came out 3 days ago. - **China SXT Pharmaceuticals** (NASDAQ:SXTC) shares increased by 24.62% to $1.62. The company's market cap stands at $1.1 million. - **Apollomics** (NASDAQ:APLM) stock rose 23.98% to $21.4. The market value of their outstanding shares is at $37.0 million. - **Kezar Life Sciences** (NASDAQ:KZR) shares moved upwards by 19.19% to $7.39. The market value of their outstanding shares is at $45.4 million. ### Losers - **Scienture Holdings** (NASDAQ:SCNX) stock declined by 37.6% to $0.26 during Monday's regular session. The market value of their outstanding shares is at $16.9 million. As per the press release, Q4 earnings came out today. - **Viridian Therapeutics** (NASDAQ:VRDN) shares declined by 33.36% to $18.25. The market value of their outstanding shares is at $2.6 billion. - **GlucoTrack** (NASDAQ:GCTK) shares decreased by 32.42% to $0.67. - **Cuprina Holdings (Cayman)** (NASDAQ:CUPR) shares declined by 28.05% to $0.29. The market value of their outstanding shares is at $2.9 million. - **Icecure Medical** (NASDAQ:ICCM) shares decreased by 25.02% to $0.28. The market value of their outstanding shares is at $27.4 million. - **Insight Molecular** (NASDAQ:IMDX) stock declined by 21.92% to $2.78. The market value of their outstanding shares is at $114.5 million. As per the news, the Q4 earnings report came out 2 days ago. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [BFRGW.US](https://longbridge.com/en/quote/BFRGW.US.md) - [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md) - [APLM.US](https://longbridge.com/en/quote/APLM.US.md) - [BFRG.US](https://longbridge.com/en/quote/BFRG.US.md) - [ITRM.US](https://longbridge.com/en/quote/ITRM.US.md) - [ICU.US](https://longbridge.com/en/quote/ICU.US.md) - [ITRMF.US](https://longbridge.com/en/quote/ITRMF.US.md) ## Related News & Research - [Squarepoint Ops LLC Purchases 133,046 Shares of Viridian Therapeutics, Inc. $VRDN](https://longbridge.com/en/news/298825537.md) - [Velan Capital Investment Management LP Has $184,000 Stock Holdings in Viridian Therapeutics, Inc. $VRDN](https://longbridge.com/en/news/297893912.md) - [Viridian Therapeutics Chief Legal Officer Jennifer Tousignant disposes of common shares worth $348,194](https://longbridge.com/en/news/296547459.md) - [SeaStar Medical CFO Michael Messinger acquires 750 common shares worth $2,452.5](https://longbridge.com/en/news/296396582.md) - [Apollomics CEO Chen Hung-Wen reports purchase of $7,450,008 Class A shares](https://longbridge.com/en/news/296153680.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**